I hope this rockstar CEO has some pedigree in his CV.
Even janitor at Gilead would do me.
Where this CEO comes from might give us an insight into what programs of ours might enjoy some favoritism... A Gilead type might favour LANI and Hep C while a Medimmune type might give alot of loving to RSV etc.
He/she better have lots of antiviral experience under their belts... No greenhorn puhlease....
- Forums
- ASX - By Stock
- BTA
- hep c dispute
hep c dispute, page-14
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)